Sabine Hojas

Azacitidine for Front-Line Therapy of Patients with AML: Reproducible Efficacy Established by Direct Comparison of International Phase 3 Trial Data with Registry Data from the Austrian Azacitidine Registry of the AGMT Study Group

Lisa Pleyer, Hartmut Döhner, Hervé Dombret et al. · International Journal of Molecular Sciences · 2017 · 51 citations · Full text

Medicine, Hematology, Pharmacology +12

Comparison of three commercial decision support platforms for matching of next-generation sequencing results with therapies in patients with cancer

Samantha Perakis, Sabrina Weber, Qing Zhou et al. · ESMO Open · 2020 · 42 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Azacitidine front-line in 339 patients with myelodysplastic syndromes and acute myeloid leukaemia: comparison of French-American-British and World Health Organization classifications

Lisa Pleyer, Sonja Burgstaller, Reinhard Stauder et al. · Journal of Hematology & Oncology · 2016 · 41 citations · Full text

Medicine, Hematology, Pharmacology +16

Monitoring of minimal residual disease in patients with <i>MLL–AF6</i>‐positive acute myeloid leukaemia by reverse transcriptase polymerase chain reaction

Gerlinde Mitterbauer, Christine L. Zimmer, Hendrati Pirc‐Danoewinata et al. · British Journal of Haematology · 2000 · 35 citations

Medicine, Hematology, Molecular Genetics +17

Megakaryocytic Morphology and Clinical Parameters in Essential Thrombocythemia, Polycythemia Vera, and Primary Myelofibrosis With and Without JAK2 V617F

Nataliya Vytrva, Elvira Stacher, Peter Regitnig et al. · Archives of Pathology & Laboratory Medicine · 2014 · 23 citations

Medicine, Hematology, Pathology +17